Physiological Concentration of Prostaglandin E2 Exerts Anti-inflammatory Effects by Inhibiting Microglial Production of Superoxide Through a Novel Pathway.
Shih-Heng ChenYueh-Feng SungEsteban A OyarzabalYu-Mei TanJeremy LeonardMingri GuoShuo LiQingshan WangChun-Hsien ChuShiou-Lan ChenRu-Band LuJau-Shyong HongPublished in: Molecular neurobiology (2018)
This study investigated the physiological regulation of brain immune homeostasis in rat primary neuron-glial cultures by sub-nanomolar concentrations of prostaglandin E2 (PGE2). We demonstrated that 0.01 to 10 nM PGE2 protected dopaminergic neurons against LPS-induced neurotoxicity through a reduction of microglial release of pro-inflammatory factors in a dose-dependent manner. Mechanistically, neuroprotective effects elicited by PGE2 were mediated by the inhibition of microglial NOX2, a major superoxide-producing enzyme. This conclusion was supported by (1) the close relationship between inhibition of superoxide and PGE2-induced neuroprotective effects; (2) the mediation of PGE2-induced reduction of superoxide and neuroprotection via direct inhibition of the catalytic subunit of NOX2, gp91phox, rather than through the inhibition of conventional prostaglandin E2 receptors; and (3) abolishment of the neuroprotective effect of PGE2 in NOX2-deficient cultures. In summary, this study revealed a potential physiological role of PGE2 in maintaining brain immune homeostasis and protecting neurons via an EP receptor-independent mechanism.
Keyphrases
- lps induced
- inflammatory response
- hydrogen peroxide
- neuropathic pain
- cerebral ischemia
- lipopolysaccharide induced
- spinal cord
- high glucose
- white matter
- diabetic rats
- signaling pathway
- oxidative stress
- reactive oxygen species
- brain injury
- photodynamic therapy
- social support
- depressive symptoms
- blood brain barrier
- risk assessment
- high resolution
- stress induced
- binding protein